Europe Hemostasis & Tissue Sealing Agents Market Size & Outlook
Europe hemostasis & tissue sealing agents market, 2018-2030 (US$M)
Related Markets
Europe hemostasis & tissue sealing agents market highlights
- The Europe hemostasis & tissue sealing agents market generated a revenue of USD 2,294.6 million in 2023.
- The market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
- In terms of segment, topical hemostat was the largest revenue generating product in 2023.
- Adhesive & tissue sealant is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 2,294.6 million |
| Market revenue in 2030 | USD 3,101.5 million |
| Growth rate | 4.4% (CAGR from 2023 to 2030) |
| Largest segment | Topical hemostat |
| Fastest growing segment | Adhesive & tissue sealant |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical hemostat, Adhesive & tissue sealant |
| Key market players worldwide | Johnson & Johnson, Cryolife, Cohera Medical, Pfizer Inc, Becton Dickinson & Co, Baxter International Inc, HyperBranch Medical Technology, Zimmer Biomet Holdings Inc, B. Braun Medical, Smith & Nephew PLC, Advanced Medical Solutions, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.7% of the global hemostasis & tissue sealing agents market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 954.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hemostasis & Tissue Sealing Agents Market Scope
Hemostasis & Tissue Sealing Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe hemostasis & tissue sealing agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemostasis & tissue sealing agents market will help companies and investors design strategic landscapes.
Topical hemostat was the largest segment with a revenue share of 62.97% in 2023. Horizon Databook has segmented the Europe hemostasis & tissue sealing agents market based on topical hemostat, adhesive & tissue sealant covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is the second largest region in the market in 2016 due to the rise in geriatric population, increase in number of surgeries being performed, and the use of sealing & adhesive agents to avoid postoperative risk of bleeding.
Advanced tissue sealing agents, such as Ethicon OMNEX, a synthetic surgical sealant commonly used in vascular surgery, are available in Europe and are approved by the European Medicines Agency.
Reasons to subscribe to Europe hemostasis & tissue sealing agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe hemostasis & tissue sealing agents market databook
-
Our clientele includes a mix of hemostasis & tissue sealing agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hemostasis & tissue sealing agents market , including forecasts for subscribers. This continent databook contains high-level insights into Europe hemostasis & tissue sealing agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe hemostasis & tissue sealing agents market size, by country, 2018-2030 (US$M)
Europe Hemostasis & Tissue Sealing Agents Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
